Cognitive Genetics and Cognitive Therapy Group

Our work in cognitive genetics has focused on characterising the effects of genetic variants linked to risk for psychosis on brain structure and function. Aspects of brain structure, such as brain volume and white matter integrity, and brain functions, such as cortical activations that occur during information processing  are likely to mediate the effects of genetic variants on illness. In what’s often described as an intermediate or 'endophenotype' approach, studying these brain based ‘phenotypes’ may help bring us closer to the mechanism of gene activity so as to understand the broader illness phenotype.  To do this our work draws on neuropsychological, electrophysiological, and neuro-imaging techniques for investigating the role of gene function at the level of individual brain systems.

Our research is focussed on the key question: how do genes increase risk for psychosis? To address this question we are studying the effects of recently identified psychosis risk genes on brain structure and brain function. Identifying and charactiersing how neural systems are affected by risk genes can tell us much about the neurobiology of the psychosis, a key requirement for the development of new treatments. Two recent developments in this work include focusing on risk genes effects on aspects of social cognition, and communication or ‘connectivity’ between brain regions.

    1. Social cognitive neuroscience

    Disability in schizophrenia (SZ) results from, and is predicted by, deficits in social cognition that are not targeted by current treatments. Targeting these deficits is challenging because the underlying neural mechanisms are poorly understood. The purpose of our research into this area is twofold: (1) to delineate patterns of abnormal activations within cortical and sub-cortical regions during performance of social cognition tasks; (2) to comprehensively evaluate the impact on social cognition of common and rare genetic variation contributing to the genetic architecture of schizophrenia and related phenotypes. Investigating the biology of social cognition in SZ patients rather than simply in healthy participants is relatively novel for our field. Moreover, analysis of imaging data on patients and controls collected here, together with our existing behavioural social cognition data and genome data, uniquely positions us to establish the effects of risk variants on social cognition at the level of behaviour, cortical activation, and neuroanatomy.

      2. Neural Connectivity

      Neural connectivity has recently been proposed as an intermediate phenotype for schizophrenia.  In the CogGene lab, we are examining the effects of specific schizophrenia risk variants on:

      1. Structural connectivity: the white matter tracts connecting different parts of the brain

      2. Functional connectivity: the correlation of activity between different parts of the brain

      3. Effective connectivity: the effect of one group of neurons on another

      To carry out this research, we are using diffusion tensor imaging (DTI) and functional magnetic resonance imaging (fMRI), with analysis techniques including DTI tractography, psychophysiological interactions (PPI) and dynamic causal modelling (DCM).  Characterising the effects of these variants on neural networks has the potential to further elucidate the mechanisms by which they increase risk, which may guide future treatment strategies.

      Diffusion tensor imaging of white matter tracts in the brain

      Research Volunteers needed

      For details on how to participate in our research please click 'Volunteers Needed'. 

        1. Neuropsychological Assessment

        Measures of neuropsychological ability, including general cognitive ability (IQ), memory, and attention have been extensively used to investigate variance in cognition in both health controls and patients. This provides a relatively simple and cost-effective strategy for measuring the effects of individual genes on cognition in large numbers of individuals.

          2. Electrophysiological Tests

          The use of high density EEG to study variance in sensory information processing, both at early and late processing stages involves a non-invasive measurement of electrical impulses picked up by scalp electrodes. This approach allows mili-second accuracy in recording brain responses to visual and auditory stimuli.

          3. Neuroimaging Approaches

          This involves the use of MRI for a wide range of purposes, including measurement of grey and white matter density, white matter integrity (DTI), and functional MRI (fMRI). Collectively, these approaches provide millimetre accuracy in investigating the influence of individual genes on brain structure and function.

          Book Chapters
          1. Burdick K, Glicksberg B, Donohoe G. Genetic Influences on Cognition in Schizophrenia. Genetic Influences on Cognition in Schizophrenia. Cognitive Impairment in Schizophrenia: Characteristics, Assessment and Treatment. Ed Philip Harvey. Cambridge University Press, Cambridge, UK. (In press).
          2. Corvin A, Donohoe G, Hargreaves A, Gallagher L, Gill M. The Cognitive Genetics of Neuropsychiatric Disorders. Curr Top Behav Neurosci. 2012 Feb 26. [Epub ahead  of print] PubMed PMID: 22367920. 
          3. Donohoe G, Goldberg TE, Corvin A. Cognitive intermediate phenotypes in schizophrenia genetics. In TE Goldberg and D Weinberger (Eds) The Genetics of Cognitive neuroscience, 2009 Boston: MIT Press.
          4. Waddington JL, Corvin AP, Donohoe G, O'Tuathaigh CM, Mitchell KJ, Gill M. Functional genomics and schizophrenia: endophenotypes and mutant models. Psychiatr Clin North Am. 2007 Sep;30(3):365-99. Review. PubMed PMID: 17720028.  hg gf 
          Journal Articles
          1. *Rose EJ, Donohoe G. Brain vs. behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia. Schizophrenia Bulletin (In Press).
          2. *Donohoe G, Duignan A, Hargreaves A, Morris DW, Rose EJ, Robertson D, Cummings E, Moore S, Gill M, Corvin A. Social Cognition In Bipolar Disorder Versus Schizophrenia:  Comparability of Mental State Decoding Deficits. Bipolar Disorders (In Press).
          3. *Rose EJ, Morris DW, Fahey C, Robertson IH, Greene C,  Doherty J, Newell FN, Garavan H, McGrath J, Bokde A, Tropea D, Gill M, Corvin AP, Donohoe G.The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function. Twin Research and Human Genetics (In Press).
          4. *Mothersill O, Kelly S, Rose EJ, Donohoe G. The effects of psychosis risk variants on brain connectivity: a review. Frontiers In Psychiatry (In Press).
          5. Pertl M, Hevey D, Donohoe G, Collier S. Assessing Patients’ Beliefs About Their Cancer-Related Fatigue: Validation of an Adapted Version of the Illness Perception Questionnaire J Clin Psychol Med Settings (In Press).
          6. Gilks WP, Hill M, Gill M, Donohoe G, Corvin AP, Morris DW. Functional investigation of a schizophrenia GWAS signal at the CDC42 gene. World J Biol Psychiatry. 2012 Mar 5. [Epub ahead of print] PubMed PMID: 22385474.  
          7. *Rose EJ, Greene C, Kelly S, Morris DW, Robertson IH, Fahey C, Jacobson S, O'Doherty J, Newell FN, McGrath J, Bokde A, Garavan H, Frodl T, Gill M, Corvin AP, Donohoe G. The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals. Neuroimage. 2012 Mar;60(1):614-22. Epub 2011 Dec 29. PubMed PMID: 22227051.  
          8. *Donohoe G, Schmidt H, Robertson IH. Cognitive remediation for schizophrenia: What works for whom? 2011. Irish Journal of Psychological Medicine, 28(4) 414-424.
          9. Jablensky A, Angelicheva D, Donohoe G, Cruickshank M, Azmanov DN, Morris DW,  McRae A, Weickert CS, Carter KW, Chandler D, Alexandrov B, Usheva A, Morar B, Verbrugghe PL, Filipovska A, Rackham O, Bishop AR, Rasmussen KO, Dragovic M, Cooper M, Phillips M, Badcock J, Bramon-Bosch E, Almeida OP, Flicker L, Gill M, Corvin A, Macgregor S, Kalaydjieva L. Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia. Mol Psychiatry. 2011 Oct 4. doi: 10.1038/mp.2011.129. [Epub ahead  of print] PubMed PMID: 21968932.  
            1. Gilks WP, Hill M, Gill M, Donohoe G, Corvin AP, Morris DW. Functional investigation of a schizophrenia GWAS signal at the CDC42 gene. World J Biol Psychiatry. 2012 Mar 5. [Epub ahead of print] PubMed PMID: 22385474.  
            2. *Rose EJ, Greene C, Kelly S, Morris DW, Robertson IH, Fahey C, Jacobson S, O'Doherty J, Newell FN, McGrath J, Bokde A, Garavan H, Frodl T, Gill M, Corvin AP, Donohoe G. The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals. Neuroimage. 2012 Mar;60(1):614-22. Epub 2011 Dec 29. PubMed PMID: 22227051.  
            3. *Donohoe G, Schmidt H, Robertson IH. Cognitive remediation for schizophrenia: What works for whom? 2011. Irish Journal of Psychological Medicine, 28(4) 414-424.
            4. Jablensky A, Angelicheva D, Donohoe G, Cruickshank M, Azmanov DN, Morris DW,  McRae A, Weickert CS, Carter KW, Chandler D, Alexandrov B, Usheva A, Morar B, Verbrugghe PL, Filipovska A, Rackham O, Bishop AR, Rasmussen KO, Dragovic M, Cooper M, Phillips M, Badcock J, Bramon-Bosch E, Almeida OP, Flicker L, Gill M, Corvin A, Macgregor S, Kalaydjieva L. Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia. Mol Psychiatry. 2011 Oct 4. doi: 10.1038/mp.2011.129. [Epub ahead  of print] PubMed PMID: 2196893 J, Bramon-Bosch E, Almeida OP, Flicker L, Gill M, Corvin A, Macgregor S, Kalaydjieva L. Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia. Mol Psychiatry. 2011 Oct 4. doi: 10.1038/mp.2011.129.
            5. Cruickshank M, Azmanov DN, Morris DW,  McRae A, Weickert CS, Carter KW, Chandler D, Alexandrov B, Usheva A, Morar B, Verbrugghe PL, Filipovska A, Rackham O, Bishop AR, Rasmussen KO, Dragovic M, Cooper M, Phillips M, Badcock J, Bramon-Bosch E, Almeida OP, Flicker L, Gill M, Corvin A, Macgregor S, Kalaydjieva L. Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia. Mol Psychiatry. 2011 Oct 4. doi: 10.1038/mp.2011.129. [Epub ahead  of print] PubMed PMID: 2196893 J, Bramon-Bosch E, Almeida OP, Flicker L, Gill M, Corvin A, Macgregor S, Kalaydjieva L. Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia. Mol Psychiatry. 2011 Oct 4. doi: 10.1038/mp.2011.129.Cruickshank M, Azmanov DN, Morris DW,  McRae A, Weickert CS, Carter KW, Chandler D, Alexandrov B, Usheva A, Morar B, Verbrugghe PL, Filipovska A, Rackham O, Bishop AR, Rasmussen KO, Dragovic M, Cooper M, Phillips M, Badcock J, Bramon-Bosch E, Almeida OP, Flicker L, Gill M, Corvin A, Macgregor S, Kalaydjieva L. Promoter polymorphisms in two ove
          Book Reviews
          Donohoe G. Book Review: ‘Genes brain and Development. The neurocognition of genetics disorders. In Neuropsychological rehabilitation, 2010. 20(5) 798-799.
          Non-Peer reviewed
          1. Donohoe G, Spolletini I. Researching the DSM-V: Current questions and likely answers. Irish Psychologist, 2008. 34 (8): 217-221.
          2. Greene BR, Meredith S, Reilly R, Donohoe G (2004) A novel, portable eye tracking system for use in schizophrenia research Irish Signals and Systems Conference, 2004, P89-94.
          3. Donohoe G, Compliance with neuroleptics in Schizophrenia., Irish Medical Times, 2002 (Feb), 2002, p32
          4. Donohoe G, Is your child depressed?, Frontline, 48, 2001, p28
          5. Donohoe G et al., Differences in cognitive, social, and physical resources between depressed and non-depressed older people. Thornfield Journal, 21, 1999, p11-18
          6. Donohoe G, Burnt People: Living in l’Arche, Furrow, 98, (2), 1997, p95-101
          Conference Proceedings

          Rose, E.J., Hargreaves, A., Morris, D.W., Fahey, C., Gill, M., Corvin,
          A., and Donohoe,G. The novel psychosis risk variant rs7914558 at CNNM2 is
          associated with variability in social cognitive function and gray matter
          volume. Cognitive Neuroscience Society, Chicago, IL, USA.  March 2012.

          Rose, E.J., Greene, C., Morris, D.W., Fahey, C., Robertson, I., Garavan,
          H., Gill, M., Corvin, A.P., and Donohoe, G.  The NOS1 polymorphism
          rs6490121 is associated with variation in prefrontal function and gray
          matter density in healthy individuals. Organization
          for Human Brain Mapping, Quebec, Canada, June 2011.

          Rose, E.J., Mothersill, O., Greene, C., Kelly, S., Morris, D.W., Fahey,
          C., Robertson, I., Garavan, H., Gill, M., Corvin, A.P., and Donohoe, G.
          The putative NOS1 schizophrenia risk variant rs6490121 is associated with
          prefrontal function and gray matter density in healthy individuals. Wiring the Brain, Ireland, April 2011.

          O'Donoghue, T; Morris, Dw; Fahey, C; Da Costa, A; Foxe, Jj; Hoerold, D; Gill, M; Corvin, A; Donohoe, G. The Nos1 Variants Rs6490121 Previously Associated With Both Schizophrenia And Poorer Cognitive Performance Also Influences Early Visual Processing In Healthy Participants Irish conference of Medical Genetics, Belfast, 2011.                                                               

           

           

          Details on current vacancies are available on the trinity college vacancies website at: www.tcd.ie/vacancies

          The work of the CogGene lab is generously sponsored by Science foundation Ireland, the Higher Education Authority (Ireland), the Wellcome trust, and NARSAD.

          Brain images constructed using MRIcroGL (http://www.mccauslandcenter.sc.edu/mricrogl/).

          Gary Donohoe, Associate Professor in Clinical Neuropsychology, Group Leader

          Derek Morris, Assistant Professor of Molecular Psychiatry

          Ken OReilly, Lecturer in Clinical Psychology

          Craig Chigwedere, Lecturer in CBT

          Emma Jane Rose, Research Fellow

          Deepa Pal, Research Fellow

          April Hargreaves, PhD Student

          Sinéad Kelly, PhD Student

          Omar Mothersill, PhD Student

          Rachel Dillon, PhD Student

          Ana McLaughlin, PhD Student